Catalog No.
Product Name
Application
Product Information
Citations
-
Anti-ophthalmic Disorders Agent
BIZ 114 is a fatty acid derivative that actively inhibits the TNF-α activated NF-κB pathway. It demonstrates significant potential in the prevention and treatment of ophthalmic disorders, including retinal degenerative conditions and ocular inflammatory diseases. This compound is valuable for research investigating the molecular mechanisms underlying these disorders and developing targeted therapeutic strategies. -
NF-κB Activator
Methylchloroisothiazolinone is a potent NF-κB activator known for its pro-inflammatory properties. It induces the expression of pro-inflammatory cytokines, including IL-1β, TNF-α, and IL-6, through the activation of the NF-κB signaling pathway and upregulation of TLR4. This compound is utilized in research focusing on allergic contact dermatitis and immunotoxicity mechanisms. Additionally, Methylchloroisothiazolinone demonstrates neurotoxic effects and has been shown to impair cholinesterase activity, leading to increased oxidative stress and detrimental impacts on aquatic organisms, specifically Mediterranean mussels. -
NF-κB Inhibitor
HSR1304 is a potent NF-κB inhibitor that targets the multifunctional transcription factor involved in various human diseases, including cancer and chronic inflammation. This compound demonstrates significant biological activity in modulating NF-κB signaling pathways. HSR1304 is intended for research applications focused on cancer biology and the development of anti-inflammatory strategies. -
NF-κB Inhibitor
Rubioncolin C is a potent NF-κB inhibitor that demonstrates significant anti-tumor activity. It promotes apoptotic and autophagic cell death in human cancer cells while effectively suppressing the NF-κB and Akt/mTOR/P70S6K signaling pathways. This compound is valuable for research focused on cancer biology and therapeutic development. -
NF-κB Inhibitor
(−)-N-Hydroxyapiosporamide is a potent NF-κB inhibitor known for its significant antitumor activity both in vitro and in vivo. Its biological properties make it particularly relevant for research applications targeting colorectal cancer (CRC). This alkaloid serves as a valuable tool for studying the mechanisms of NF-κB signaling and its role in tumor progression. -
Anti-inflammatory Agent
Ageconyflavone B is a flavonoid that functions as an anti-inflammatory agent. It effectively reduces inflammation through the inhibition of IκBα phosphorylation, thereby modulating the NF-κB signaling pathway. This compound is relevant for research applications focused on inflammatory diseases and the underlying molecular mechanisms of inflammation. -
NF-κB
NF-κB-IN-2 is a selective inhibitor of NF-κB signaling. It effectively suppresses TNF-α-induced canonical NF-κB pathway activation in PC-3 cells, demonstrating significant potential in studies related to inflammation, cell survival, and cancer research. This compound is valuable for investigating the role of NF-κB in various biological processes and therapeutic applications. -
NF-κB Modulator
IMD-biphenylC is an imidazoquinolinone-NF-κB modulator that functions through the inhibition of NF-κB signaling pathways. It exhibits significant biological activity by suppressing tumor proliferation while promoting a favorable inflammatory response. This compound is valuable for research applications focused on cancer biology and the modulation of immune responses, particularly in evaluating therapies that minimize systemic inflammation and adjuvant toxicity. -
Protein Complex Stabilizer
ADHPE is a protein complex stabilizer that targets the 14-3-3σ and p65 proteins. It effectively inhibits the NF-κB (p65) signaling pathway, leading to a reduction in inflammatory responses. This reagent is suitable for research applications focusing on pediatric pneumonia-related acute lung injury and acute respiratory distress syndrome. -
NF-κB Inhibitor
NF-κB-IN-3 is a potent NF-κB inhibitor with an IC50 of 0.70 µM. It exhibits significant biological activity by disrupting the NF-κB signaling pathway, which is crucial in various cellular processes including inflammation and cancer progression. This compound is utilized in research applications focused on cancer biology and therapeutic interventions targeting NF-κB-related pathways. -
NF-κB Inhibitor
Stipuleanoside R2 is a potent inhibitor of NF-κB activation, specifically blocking the pathway triggered by TNFα. This compound demonstrates dose-dependent inhibitory activity, with an IC50 value of 4.1 μM. Stipuleanoside R2 can be utilized in research focused on inflammatory response, cancer biology, and other diseases associated with NF-κB signaling. -
Anti-inflammatory Agent
BS-153 is a synthetic oxazolidinone compound that functions as an anti-inflammatory agent by inhibiting the activation of the NF-κB/PKCθ signaling pathway. It effectively reduces the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), as well as pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, in LPS-stimulated RAW264.7 macrophage cells. This reagent is suitable for research applications focused on inflammation and immune response modulation. -
NF-κB Inhibitor
Andrographolide-lipoic acid is an NF-κB inhibitor that combines Andrographolide and Lipoic acid. This compound exhibits significant anti-diabetic properties and provides protective effects on pancreatic β-cells. Its ability to modulate inflammatory pathways makes it a valuable tool for research in diabetes and related metabolic disorders. -
NF-κB Inhibitor
6-O-p-Hydroxybenzoylglutinoside is a selective NF-κB inhibitor that effectively suppresses TNF-α-activated NF-κB transcriptional activity, with an IC50 of 52.78 μM. This compound demonstrates targeted biological activity without significantly inhibiting soluble epoxide hydrolase (sEH), acetylcholinesterase (AChE), or butyrylcholinesterase (BChE). Isolated from the seeds of Catalpa bungei (Manchurian catalpa), 6-O-p-Hydroxybenzoylglutinoside is valuable for research applications focused on inflammation and signal transduction pathways. -
NF-κB Inhibitor
NF-κB-IN-10 is a potent inhibitor of the NF-κB signaling pathway, primarily targeting NF-κB activation. This compound has demonstrated the ability to alleviate heart failure by mitigating oxidative stress and inflammation through the modulation of the Nrf2/NF-κB axis. In RAW264.7 cells, NF-κB-IN-10 effectively inhibits lipopolysaccharide-induced nitric oxide production, as well as the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). This reagent is invaluable for research into cardiovascular diseases and related inflammatory processes. -
NF-κB Inhibitor
IKKγ NBD Inhibitory Peptide is a selective inhibitor of NF-κB signaling. It functions by disrupting the interaction between the IKKγ/NEMO-binding domain and IKKα/IKKβ, effectively blocking TNF-α-induced NF-κB activation. This peptide exhibits significant anti-inflammatory properties and has potential applications in studying cerebral ischemia and its associated neurological deficits. -
NF-κB Inhibitor
(Rac)-Myrislignan is a potent NF-κB inhibitor derived from Myristica fragrans Houtt. This compound demonstrates significant anti-inflammatory properties by effectively reducing LPS-induced inflammatory responses in murine macrophage cells. Its ability to inhibit the NF-κB signaling pathway makes (Rac)-Myrislignan a valuable tool for research into inflammation and related diseases. -
Antineuropathic Pain Agent
Lemnalol is a ylangene-type sesquiterpenoid compound that serves as a potent antineuropathic pain agent. It exhibits significant anti-inflammatory, analgesic, and antitumor activities, effectively attenuating hyperalgesia and allodynia through the modulation of neuroinflammatory processes associated with neuropathic conditions. Additionally, Lemnalol influences LPS-induced alterations in left atrial calcium homeostasis and inhibits NF-κB pathways, potentially mitigating LPS-induced arrhythmogenic effects and neuropathic pain. These properties make Lemnalol a valuable tool for pain research and the study of neuroinflammatory mechanisms. -
NF-κB Inhibitor
Helenalin isobutyrate is an NF-κB (p65 subunit) inhibitor known for its anti-inflammatory properties. It functions by irreversibly alkylating cysteine sulfhydryl groups within the p65 subunit, effectively diminishing the DNA binding activity of the NF-κB complex. This compound is valuable in research focused on understanding inflammation pathways and potential therapeutic interventions in related diseases. -
NF-κB Inhibito
Pratol is a potent inhibitor of NF-κB, effectively attenuating the production of nitric oxide (NO) and prostaglandin E2 (PGE2) in LPS-stimulated RAW 264.7 cells without exhibiting cytotoxic effects. By inhibiting NF-κB, Pratol also reduces the levels of proinflammatory cytokines. This compound is valuable for research applications focused on inflammatory diseases and cancer. -
Anti-Inflammatory Agent
8α-Hydroxyhirsutinolide is a sesquiterpene lactone that acts as an anti-inflammatory agent by inhibiting TNF-α-induced NF-κB activity with an IC50 of 1.9 μM. Additionally, it reduces nitric oxide production, indicating a potential role in modulating inflammatory pathways. This compound can be isolated from the plant Vernonia cinerea and is useful for research in inflammation and related cellular signaling mechanisms. -
NF-κB Modulator
IMD-catechol is a dimeric imidazoquinolinone that functions as a modulator of NF-κB signaling. This compound enhances therapeutic efficacy in models of CT26 colon carcinoma while demonstrating minimal adjuvant toxicity. Its unique mechanism makes it a valuable tool for investigating immune modulation and therapeutic strategies in cancer research. -
NF-κB Inhibitor
Sootepin D is a triterpene that serves as an NF-κB inhibitor. It effectively suppresses TNF-α-induced NF-κB activity with an IC50 of 8.3 μM, demonstrating significant anti-inflammatory properties. This compound is valuable for research applications focused on inflammation and related signaling pathways. -
NIK Inhibitor
AM-0216 is a potent inhibitor of NF-κB-inducing kinase (NIK), exhibiting a Ki value of 2 nM. This compound selectively modulates NF-κB signaling pathways, making it valuable for investigating NF-κB-dependent hematologic malignancies, such as multiple myeloma, as well as autoimmune disorders. The specificity and efficacy of AM-0216 position it as a significant tool in the study of related therapeutic targets and disease mechanisms. -
NF-κB Inhibitor
NF-κB-IN-8 is a selective NF-κB inhibitor that competitively antagonizes lipopolysaccharide (LPS) binding to MD-2. This compound effectively reduces the expression of inflammatory mediators, making it a valuable tool for studying inflammatory responses. Additionally, NF-κB-IN-8 has been shown to inhibit alkaline phosphatase (ALP) activity. It is particularly relevant for research into inflammation-related conditions, such as acute lung injury (ALI). -
NF-κB Modulator
IMD-biphenylA is a novel imidazoquinolinone compound that functions as a modulator of NF-κB activity. This dimeric structure enhances the adjuvanticity of small molecule immune potentiators, making it valuable for research in immunology and therapeutic applications targeting immune responses. Its ability to influence NF-κB signaling pathways positions it as a significant reagent for exploring immune modulation and adjuvant mechanisms. -
NF-κB p65 Inhibitor
Ratutrelvir is an NF-κB p65 inhibitor that targets the translocation of NF-κB p65 from the cytoplasm to the nucleus. By reducing phosphorylation levels of NF-κB p65 and IκBα, Ratutrelvir effectively inhibits the DNA-binding activity of NF-κB p65. This compound has been demonstrated to impair migration and invasion capabilities of breast cancer cells, as well as decrease their viability and colony-forming potential, making it a valuable tool for research in luminal A breast cancer. -
Anti-atherosclerosis Agent
Paeonolsilate sodium is an anti-atherosclerosis agent that effectively inhibits oxidized low-density lipoprotein (ox-LDL)-induced macrophage foam cell formation and associated inflammation. This compound suppresses NF-κB activation and the oxidative stress response triggered by ox-LDL. Paeonolsilate sodium is a valuable reagent for studying mechanisms underlying atherosclerosis and exploring potential therapeutic strategies. -
NF-κB Inhibitor
Laurotetanine is a potent isoquinoline alkaloid functioning as an NF-κB inhibitor. It exhibits anti-asthmatic properties by modulating immune responses, specifically inhibiting IgE and histamine release, alongside reducing inflammatory reactions. Laurotetanine's mechanism involves the downregulation of MUC5AC and NF-κB signaling pathways, making it a valuable tool for research in inflammatory diseases and asthma therapy. -
NF-κB Inhibitor
Dauricinoline is a potent orally active inhibitor of NF-κB, effectively blocking NF-κB activation induced by TNF-α. This compound demonstrates significant anti-inflammatory activity, making it a valuable tool for investigating inflammatory diseases, particularly in the context of lung inflammation. Researchers may utilize Dauricinoline to explore the mechanisms underlying NF-κB-mediated signaling pathways and their role in various inflammatory conditions. -
NIK Inhibitor
NIK-IN-1 is a potent inhibitor of NF-κB-inducing kinase (NIK), a critical regulator in the NF-κB signaling pathway. This compound demonstrates significant anti-inflammatory activity and is utilized in research focused on hepatic inflammatory diseases and acute liver injury. Its application helps elucidate the role of NIK in liver pathology and potential therapeutic interventions. -
NF-κB Modulator
IMD-biphenylB is a potent NF-κB modulator known for its ability to inhibit tumor proliferation. This imidazoquinolinone dimer also demonstrates a capacity to induce low systemic inflammation and minimize adjuvant toxicity. It serves as a valuable tool for research focused on immune response modulation and cancer therapy development. -
NF-κB Pathway Inhibitor
Pterocenoid C is a potent inhibitor of the NF-κB signaling pathway. This compound demonstrates significant biological activity by modulating inflammatory responses and has potential applications in the study of diseases associated with NF-κB dysregulation, including cancer and autoimmune disorders. Pterocenoid C serves as a valuable tool for researchers investigating the intricate roles of NF-κB in various biological processes and disease mechanisms. -
NF-κB Inhibitor
mcIRBP-9 is an orally bioavailable NF-κB inhibitor that effectively reduces pro-inflammatory cytokines such as TNF-α, IL-1β, and TGF-β1 in renal tissues. Additionally, mcIRBP-9 decreases LPS-induced production of IL-1β, making it a valuable tool for studying inflammatory processes. This compound is relevant to research focused on diabetic nephropathy and type 2 diabetes mellitus, providing insights into the underlying mechanisms of these conditions. -
Anti-Inflammatory Agent
Goshonoside F5 is an anti-inflammatory agent derived from the unripe fruits of Rubus chingii. It demonstrates significant anti-inflammatory activity by inhibiting the NF-κB and MAPK signaling pathways. This compound is relevant for research applications focusing on inflammation-related conditions and the underlying molecular mechanisms. -
NF-κB Inhibitor
NF-κB-IN-17 is an NF-κB inhibitor that effectively suppresses TNF-α-induced NF-κB DNA binding activity in C2C12 cells. Its mechanistic action provides valuable insights into the modulation of inflammatory responses, making it a useful tool for research applications focused on immune regulation and cancer biology. This reagent is suitable for studies examining the NF-κB signaling pathway and its implications in various disease models. -
Amide Alkaloid
Coumaperine is an amide alkaloid known for its ability to inhibit NF-κB signaling pathways. This compound has demonstrated anticancer activity against non-small cell lung cancer and Hodgkin's lymphoma, making it valuable for cancer research. Additionally, Coumaperine derivatives exhibit antibacterial properties, further expanding their potential applications in biomedical studies. -
NF-κB
ABD-350 is a selective inhibitor of NF-κB, primarily targeting the phosphorylation of the inhibitor of NF-κB. This compound demonstrates key antiresorptive activity by promoting osteoclast apoptosis while preserving osteoblast function, making it effective in preventing ovariectomy-induced bone loss. Its application includes studying osteoclast regulation and potential therapeutic strategies for osteoporosis without interfering with bone formation driven by parathyroid hormone. -
NF-κB Inhibitor
Avenanthramide-C methyl ester is an NF-κB inhibitor that exerts anti-inflammatory effects by inhibiting the secretion of pro-inflammatory factors. This compound blocks NF-κB activation through the inhibition of IKK and IκB phosphorylation, as well as by impairing proteasome activity. Avenanthramide-C methyl ester is valuable for research applications focused on inflammation and related signaling pathways. -
NF-κB Inhibitor
Coronalolic acid acts as an NF-κB inhibitor, derived from the apical bud of Gardenia sootepenesis Hutch. This compound effectively suppresses TNF-α-induced NF-κB activation and inhibits nitric oxide (NO) production. It serves as a valuable tool for research applications focused on inflammation and immune response modulation. -
NIK Inhibtior
AM-0561 is a potent NIK inhibitor with a Ki of 0.3 nM, effectively suppressing the activity of the non-canonical NF-κB signaling pathway. By inhibiting NIK, AM-0561 significantly reduces p52 protein levels, which may contribute to the regulation of various cellular processes. This reagent is useful for research applications aimed at understanding NF-κB signaling in inflammation, immune response, and cancer biology. -
Anticancer Agent
Antiproliferative Agent-76 is an 8-sulfonamidoquinoline derivative functioning as a selective anticancer agent. It effectively inhibits the NF-κB and WNT signaling pathways, promoting apoptosis in cancer cells. This compound demonstrates notable anticancer activity against colorectal cancer and leukemia, making it a valuable tool for cancer research and therapeutic applications. -
NF-κB Inhibitor
Myrcene-d6 functions as an NF-κB inhibitor through its deuterium labeling of the natural compound myrcene. With demonstrated efficacy in inhibiting TNFα and NF-κB activity, myrcene exhibits significant anti-invasive properties, mediates cell cycle arrest, and promotes apoptosis in cancer cells. Its biological activities also include robust blood protection and anti-inflammatory effects, making it a valuable reagent for research in cancer biology and inflammatory responses. -
NF-κB Modulator
IMD-vanillin is an NF-κB modulator that functions as a novel immunomodulatory compound derived from imidazoquinolinone dimers. This reagent has demonstrated the ability to inhibit NF-κB activation, thereby modulating inflammatory responses and influencing cell survival. IMD-vanillin is suitable for research applications focused on inflammation, autoimmune diseases, and cancer, where NF-κB pathways play a crucial role. -
Chlorinated Alkaloid
Dauricumine is a chlorinated alkaloid that functions as an inhibitor of NF-κB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts. This compound is significant in research applications focused on bone metabolism and osteoclastogenesis, providing insights into the regulation of inflammatory responses and potential therapeutic approaches for bone-related disorders. -
Chromone Derivative
7-O-Methylaloesinol is a chromone derivative that exhibits notable inhibitory activity against TNFα-induced NF-κB transcriptional activation, with an IC50 value of 29.07 μM. This compound serves as a valuable tool for studying inflammatory pathways and the modulation of NF-κB signaling, contributing to research in cellular responses and potential therapeutic strategies for inflammatory diseases. -
NF-κB Inhibitor
NF-κB-IN-9 is a potent inhibitor of nuclear factor kappa B (NF-κB), functioning as a sonosensitizer with an excitation/emission wavelength of 489/628 nm. This compound exhibits significant inhibition of NF-κB signaling pathways, attributed to its dual resveratrol units. NF-κB-IN-9 demonstrates effective anti-tumor activity and exhibits pronounced sonocytotoxicity against various cancer cell lines. Additionally, NF-κB-IN-9 has shown favorable biosafety profiles in xenograft mouse models, making it a valuable tool for cancer research. -
NF-κB decoy oligonucleotide
Cupabimod is a decoy oligonucleotide designed to inhibit the transcription factor NF-κB. By sequestering NF-κB, it effectively modulates inflammatory responses and regulates gene expression associated with various diseases. This compound is utilized in research focused on inflammation, autoimmune disorders, and cancer, providing valuable insights into the role of NF-κB signaling pathways. -
NF-κB Inhibitor
Licoagrochalcone C is a flavonoid that serves as an effective inhibitor of NF-κB transcription. It demonstrates significant inhibitory activity against lipopolysaccharide (LPS)-induced nitric oxide (NO) production. This compound is valuable for research applications focused on inflammatory responses and NF-κB-related signaling pathways. -
Anti-inflammatory Agent
Catalposide is an iridoid glycoside derived from Catalpa ovata G. Don (Bignoniaceae) that acts as an anti-inflammatory agent. It effectively inhibits the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, as well as the activation of NF-κB (p65) in lipopolysaccharide-stimulated RAW 264.7 macrophages. This compound is valuable for research in inflammatory pathways and potential therapeutic interventions in inflammatory diseases.
